Efficacy and safety profile of long‐term exposure to lenalidomide in patients with recurrent multiple myeloma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|20|3680-3686

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.20, 2013-10, pp. : 3680-3686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 202-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 11, 2013-11 ,pp. : 2875-2883

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Ivabradine in Patients with Chronic Stable Angina

By  

Cardiology, Vol. 108, Iss. 4, 2007-09 ,pp. : 387-396

Karger

Access to resources Recommend Favorite

Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of Treatment

By  

Nephron Clin Pract, Vol. 110, Iss. 1, 2008-07 ,pp. : c15-c23

Karger

Access to resources Recommend Favorite

Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 643-645

Karger

Access to resources Recommend Favorite